Stock BMEA BIOMEA FUSION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Biomea Fusion, Inc.

Equities

BMEA

US09077A1060

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
12.62 USD +3.10% Intraday chart for Biomea Fusion, Inc. +10.22% -13.09%
May. 02 Biomea Fusion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 03 North American Morning Briefing : Powell Awaited -2- DJ

Evolution of the average Target Price on Biomea Fusion, Inc.

Price target over the last 5 years

History of analyst recommendation changes

39cb86f.Zgr9zF55LVx5WOFzRMeCpZ0TJz4WLlFzhteXRjsN3N8.DD-U_xBBaG4RYYkqI5jW79FXSF9MYAIS1K_RFGw_pao_e5ThDjN8OiE2jg~7ff00e89206830b3c39e93b048527d8e

Analyst Recommendations on Biomea Fusion, Inc.

Biomea Fusion Shares Decline Following JPMorgan Downgrade MT
JPMorgan Downgrades Biomea Fusion to Neutral From Overweight, Adjusts Price Target to $14 From $51 MT
Truist Securities Starts Biomea Fusion With Buy Rating, $55 Price Target MT
Scotiabank Starts Biomea Fusion at Sector Outperform With $41 Price Target MT
Barclays Adjusts Biomea Fusion Price Target to $60 From $50, Maintains Overweight Rating MT
Piper Sandler Adjusts Biomea Fusion Price Target to $45 From $40, Maintains Overweight Rating MT
Jefferies Downgrades Biomea Fusion to Hold From Buy, Cuts Price Target to $28 From $36 MT
Piper Sandler Adjusts Price Target on Biomea Fusion to $45 From $40, Maintains Overweight Rating MT
JPMorgan Chase Adjusts Price Target on Biomea Fusion to $51 From $38, Maintains Overweight Rating MT
Citigroup Raises Biomea Fusion's Price Target to $90 From $53, Keeps Buy Rating MT
HC Wainwright Adjusts Biomea Fusion Price Target to $50 From $37, Maintains Buy Rating MT
JPMorgan Raises Biomea Fusion's Price Target to $38 From $37, Maintains Overweight Rating MT
EF Hutton Assumes Biomea Fusion at Buy With $32 Price Target MT
Citigroup Adjusts Price Target on Biomea Fusion to $53 From $55, Keeps Buy Rating MT
Barclays Initiates Biomea Fusion at Overweight With $50 Price Target MT
HC Wainwright Adjusts Price Target on Biomea Fusion to $37 From $44, Maintains Buy Rating MT
HC Wainwright Adjusts Price Target on Biomea Fusion to $37 From $44, Keeps Buy Rating MT
Oppenheimer Adjusts Biomea Fusion Price Target to $47 From $25, Maintains Outperform Rating MT
Citigroup Adjusts Biomea Fusion's Price Target to $60 From $20, Maintains Buy Rating MT
EF Hutton Adjusts Price Target on Biomea Fusion to $33 From $22, Maintains Buy Rating MT
Piper Sandler Adjusts Biomea Fusion's Price Target to $40 From $16, Keeps Overweight Rating MT
Citigroup Starts Biomea Fusion at Buy With $20 Price Target MT
HC Wainwright Reiterates Buy Rating on Biomea Fusion With $37 Price Target MT
EF Hutton Adjusts Price Target on Biomea Fusion to $22 From $27, Maintains Buy Rating MT
EF Hutton Initiates Buy Rating for Biomea Fusion, Sets $27 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
12.62 USD
Average target price
49.5 USD
Spread / Average Target
+292.23%
High Price Target
90 USD
Spread / Highest target
+613.15%
Low Price Target
15 USD
Spread / Lowest Target
+18.86%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Biomea Fusion, Inc.

JPMorgan Chase
Truist Securities
Scotiabank
Jefferies & Co.
Piper Sandler
Barclays
Citigroup
HC Wainwright
EF Hutton
Oppenheimer
J.P. Morgan Chase

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BMEA Stock
  4. Consensus Biomea Fusion, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW